Tevogen Bio Holdings Inc. (TVGN)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Income | -$26.14M | -$53.56M | -$8.84M | — | — |
| Net Income | -$26.28M | -$13.73M | -$60.48M | $4.41M | — |
| EPS (Diluted) | $-8.08 | $-3.50 | $-2.44 | — | — |
| Total Assets | $4.38M | $3.46M | $5.51M | $357.14M | $352.85M |
| Total Liabilities | $12.62M | $10.14M | $99.93M | $15.06M | $15.18M |
| Shareholders' Equity | -$8.23M | -$6.67M | -$94.43M | -$33.95M | -$14.23M |
| Cash & Equivalents | $0 | $0 | $0 | $129.2K | $344.6K |
| Operating Cash Flow | -$12.33M | -$12.00M | -$8.17M | -$215.4K | — |
| Capital Expenditures | $64.4K | — | $133.0K | — | — |
| Shares Outstanding | 4.02M | 3.56M | 120.00M | 2.38M | — |